Maruho To Exclusively Sell Novartis’ Atopic Dermatitis Drug Protopic
This article was originally published in PharmAsia News
Executive Summary
Maruho will exclusively begin atopic dermatitis drug Protopic (tacrolimus), currently sold and manufactured by Astellas in Japan, starting April 1.